Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
A Phase 3 Randomized Non-Inferiority Study of Carboplatin and Vincristine versus Selumetinib NSC 748727 in Newly Diagnosed or Previously Untreated Low-Grade Glioma LGG Not Associated with BRAFV600E Mutations or Systemic Neurofibromatosis Type 1 NF1
Study Type: Treatment
Phase: III
NCTID: NCT04166409
Principal Investigator:
Keith August
Phase I study of ex vivo expanded/activated gamma delta T-cell infusion following haploidentical hematopoietic stem cell transplantation and post-transplant cyclophosphamide
Study Type: Treatment
Phase: I
NCTID: NCT03533816
Principal Investigator:
Joseph McGuirk
A Phase III Adaptive Radiation And Chemotherapy For Muscle Invasive Bladder Cancer Trial ARCHER
Study Type: Treatment
Phase: III
NCTID: NCT07097142
Principal Investigator:
Jay Shiao
Phase III Evaluation of Fixed Duration Zanubrutinib Plus Sonrotoclax-Based Therapy Compared to Continuous Zanubrutinib in Previously Untreated Older Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma CLL/SLL
Study Type: Treatment
Phase: III
NCTID: NCT07321652
Principal Investigator:
Marc Hoffmann
AN OPEN-LABEL, PHASE 1/2 DOSE ESCALATION, DOSE EXPANSION AND COHORT EXPANSION STUDY EVALUATING THE SAFETY, PK AND CLINICAL ACTIVITY OF FMC-376 MONOTHERAPY AND IN COMBINATION WITH PEMBROLIZUMAB IN PARTICIPANTS WITH KRAS G12C MUTATED ADVANCED SOLID TUMORS PROSPER
Study Type: Treatment
Phase: I/II
NCTID: NCT06244771
Principal Investigator:
Prakash Neupane
Implementing the NYU Electronic Patient Visit Assessment ePVA for Head and Neck Cancer In Rural and Urban Populations
Study Type: Supportive Care
Phase: N/A
NCTID: NCT06030011
Principal Investigator:
Chris Lominska
A Randomized Phase III Study of Neoadjuvant Chemotherapy followed by Surgery versus Surgery Alone for Patients with High Risk Retroperitoneal Sarcoma STRASS2
Study Type: Treatment
Phase: III
NCTID: NCT04031677
Principal Investigator:
Luke Selby
A Randomized Phase II Study of CHOEP vs CC-486- CHOEP vs duvelisib- CHOEP in previously Untreated CD30 Negative Peripheral T-cell Lymphomas
Study Type: Treatment
Phase: II
NCTID: NCT04803201
Principal Investigator:
Marc Hoffmann
A Phase 2 Study of Venetoclax in Relapsed Classic or Variant Hairy Cell Leukemia
Study Type: Treatment
Phase: II
NCTID: NCT06311227
Principal Investigator:
Joseph Bennett
An Open-label, Phase 1, Multi-Center Master Protocol to Evaluate the Safety and Preliminary Anti-Tumor Activity of TCR-engineered T cells Recognizing KRAS Mutations in Adult Subjects with Unresectable, Advanced, and/or Metastatic Solid Tumors
Study Type: Treatment
Phase: I
NCTID: NCT06218914
Principal Investigator:
Joaquina Baranda